Symposium Celebrating Ranjan Sen to be held January 30, 2016

senThe Biology department is cosponsoring an all-day symposium “Cellular and Molecular Immunology in Health and Disease” on Saturday, January 30. The symposium will be held in Gerstenzang 121 from 8:30 am to 6:00 pm. This symposium celebrates Ranjan Sen’s 60th birthday and is organized by Sen’s Brandeis alumni.  This symposium is open to the public, although the breakfast and lunch are by invitation only and are not open to the public.

The list of speakers includes:

  • Sen_Symposium_2016_FINALFredrick Alt, Ph.D., Harvard Medical School
  • Dipanjan Chowdhury, Ph.D., Harvard Medical School
  • David Schatz, Ph.D., Yale School of Medicine
  • Stephen Desiderio, M.D., Ph.D., John Hopkins Medicine
  • Sankar Ghosh, Ph.D., Columbia University
  • Barbara Nikolajczyk, Ph.D., Boston University
  • Stephen Smale, Ph.D., University of California, Los Angeles
  • Joel Pomerantz, Ph.D., Johns Hopkins University School of Medicine
  • Rudolf Grosschedl, Ph.D., Max Planck Institute, Germany
  • Batu Erman, Ph.D., Sabanci University, Turkey
  • Christina Jamieson, Ph.D., University of California, San Diego, School of Medicine
  • Yehudit Bergman, Ph.D., The Hebrew University of Jerusalem, Israel

More information about this event is available.

 

James P. Allison to deliver Gabbay Award Lecture

James Allison, PhD  from the Memorial Sloan-Kettering Cancer Center will receive the 2011 Jacob Heskel Gabbay Award in Biotechnology and Medicine “for his development of strategies for the treatment of autoimmune diseases and for immunotherapy of cancer”. The award, administered by the Rosenstiel Center at Brandeis, consists of a $15,000 cash prize and a medallion. Dr. Allison will deliver the award lecture on Mobilizing the immune system to treat cancer: Immune checkpoint blockade, on Monday, Nov 14, 2011 at 3:30 pm in Gerstenzang 121.

Allison and his lab are interested in the mechanisms that regulate T cell responses and using that understanding to improve clinical outcomes in areas ranging from autoimmunity, to allergy to vaccination to  tumor therapy.

From bench to clinical trials: the rFIXFc story

BrandeisNOW has a new story about the development of recombinant Factor IX Fc,  a candidate drug for hemophila, currently in Phase III cliniical trials. The story behind the Fc fusion technology started in academic labs including Neil Simister‘s at Brandeis, led to a biotech startup (Syntonix), which was then acquired by Biogen Idec, who are now conducing clinical trials.

For more, see http://www.brandeis.edu/now/2011/june/hemophilia.html

Lots of seminars coming

Whole bunch of seminars and award lectures coming up in the next week. Steven Reppert from U. Mass. talks today at 4 about monarch butterfly migration and its relationship to the circadian clock. On Monday at noon, Giovanni Bosco (PhD in Mol Cell Biol, Brandeis, 1998) will talk about condensins and global chromosome structure.

On Tuesday, we have the 39th Annual Rosenstiel Award lectures at 4. Jules Hoffman and Ruslan Medzhitov will get award “for their elucidation of the mechanisms of innate immunity”.

Next Wednesday we have the Heart Research Series lecture. Monty Krieger, Whitehead Professor of Molecular Genetics at MIT, will talk about cholesterol, genetics, and heart disease. Finally, next Thursday will have Josh Tenenbaum from MIT speaking in the Psychology Colloquium about “How to Grow a Mind”.

Details (time, room number) about upcoming seminars are always available in the Seminars widget in the left-hand column on this blog.

Protected by Akismet
Blog with WordPress

Welcome Guest | Login (Brandeis Members Only)